TrialAdvances in therapy2015

Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects.

Makoto Araie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.